Diabetes 52:852-856, 2003
© 2003 by the American Diabetes Association, Inc.
Increased Serum IGF-I During Pregnancy Is Associated With Progression of Diabetic Retinopathy
Finn F. Lauszus1,
Joachim G. Klebe1,
Toke Bek2, and
Allan Flyvbjerg3
1 Department of Obstetrics/Gynecology, Skejby Hospital, Aarhus University Hospital, Aarhus, Denmark
2 Ophthalmologic Department, Aarhus University Hospital, Aarhus, Denmark
3 Medical Research Laboratories, Aarhus University Hospital, Aarhus, Denmark
The IGF system has been associated with development and progression of diabetic retinopathy. We examined whether a simple measurement of the IGF system (serum total IGF-I) correlated with progression of diabetic retinopathy in pregnancy in type 1 diabetes. A prospective observational study was performed in 103 pregnant women with type 1 diabetes. Serum IGF-I was measured in maternal serum from week 14, every fourth week until week 30, and every second week until delivery. Twenty-fourhour blood pressure was measured with a portable oscillometry monitor. The women had visual acuity testing and fundus photography before pregnancy, once in each trimester, and 4 months after birth. Each eye was assigned an overall retinopathy grade on a scale from 1 to 6 independently by two experienced graders. During pregnancy, serum IGF-I increased with increasing gestational age until a plateau was reached in week 32. Progression of retinopathy was significantly associated with a higher level of IGF-I (P < 0.01). Serum IGF-I increased with increasing progression of retinopathy. Change of retinopathy was significantly associated with level of IGF-I (P < 0.01). During pregnancy, serum IGF-I increased with increasing birth weight until a plateau was reached in week 32. Birth weight was significantly associated with a higher level of serum IGF-I (P < 0.01).

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Treins, S. Giorgetti-Peraldi, J. Murdaca, M.-N. Monthouel-Kartmann, and E. Van Obberghen
Regulation of Hypoxia-Inducible Factor (HIF)-1 Activity and Expression of HIF Hydroxylases in Response to Insulin-Like Growth Factor I
Mol. Endocrinol.,
May 1, 2005;
19(5):
1304 - 1317.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A R Hayati, F C Cheah, J F Yong, A E Tan, and W M Norizah
The role of serum insulin-like growth factor I (IGF-I) in neonatal outcome
J. Clin. Pathol.,
December 1, 2004;
57(12):
1299 - 1301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Mesotten, P. J. Wouters, R. P. Peeters, K. V. Hardman, J. M. Holly, R. C. Baxter, and G. Van den Berghe
Regulation of the Somatotropic Axis by Intensive Insulin Therapy during Protracted Critical Illness
J. Clin. Endocrinol. Metab.,
July 1, 2004;
89(7):
3105 - 3113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Fuglsang, F. Lauszus, A. Flyvbjerg, and P. Ovesen
Erratum
J. Clin. Endocrinol. Metab.,
October 1, 2003;
88(10):
5042 - 5042.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Fuglsang, F. Lauszus, A. Flyvbjerg, and P. Ovesen
Human Placental Growth Hormone, Insulin-Like Growth Factor I and -II, and Insulin Requirements during Pregnancy in Type 1 Diabetes
J. Clin. Endocrinol. Metab.,
September 1, 2003;
88(9):
4355 - 4361.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Diabetes Association.
|
|
| |
|